Physician profile
Lorie Thomas-Schultz
NPI 1568440097
$92,273.14
in general payments reported to CMS, 2019-2025
14 companies · $28K in 2025
The $28K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2020: $130 · 2021: $57.36 · 2022: $11K · 2023: $8,368 · 2024: $44K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $60K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $4,304 · Travel and Lodging: $4,082.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $60,069.99 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,000.00 |
| Food and Beverage | $4,304.18 |
| Travel and Lodging | $4,082.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $91,170.79 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Novo Nordisk INC | $275.90 | 2020-2025 | Wegovy |
| Axonics, INC. | $225.56 | 2021-2024 | Axonics |
| Astellas Pharma US INC | $175.54 | 2023-2024 | Veozah |
| Alexion Pharmaceuticals, INC. | $125.00 | 2024 | Ultomiris |
| Dexcom, INC. | $95.00 | 2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Allergan, INC. | $57.81 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $38.40 | 2023 | Reblozyl |
| Conmed Corporation | $26.99 | 2022 | |
| Medtronic, INC. | $20.27 | 2022 | |
| Urovant Sciences INC | $17.34 | 2022 | |
| Hologic Sales and Service, LLC | $16.37 | 2025 | Aptima |
| Minerva Surgical, INC | $14.64 | 2024 | |
| Abbvie INC. | $13.53 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorie Thomas-Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.